4.6 Article

Central and Peripheral Blood Flow During Exercise With a Continuous-Flow Left Ventricular Assist Device Constant Versus Increasing Pump Speed: A Pilot Study

Journal

CIRCULATION-HEART FAILURE
Volume 4, Issue 5, Pages 554-560

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCHEARTFAILURE.110.958041

Keywords

heart failure; cerebrovascular circulation; cardiac output; left ventricular assist device

Funding

  1. Fonds de la recherche en sante du Quebec
  2. Danish Heart Foundation
  3. Thoratec Inc.

Ask authors/readers for more resources

Background-End-stage heart failure is associated with impaired cardiac output (CO) and organ blood flow. We determined whether CO and peripheral perfusion are maintained during exercise in patients with an axial-flow left ventricular assist device (LVAD) and whether an increase in LVAD pump speed with work rate would increase organ blood flow. Methods and Results-Invasively determined CO and leg blood flow and Doppler-determined cerebral perfusion were measured during 2 incremental cycle exercise tests on the same day in 8 patients provided with a HeartMate II LVAD. In random order, patients exercised both with a constant (approximate to 9775 rpm) and with an increasing pump speed (+400 rpm per exercise stage). At 60 W, the elevation in CO was more pronounced with increased pump speed (8.7 +/- 0.6 versus 8.1 +/- 1.1 L . min(-1); mean +/- SD; P=0.05), but at maximal exercise increases in CO (from 7.0 +/- 0.9 to 13.6 +/- 2.5 L . min(-1); P<0.01) and leg blood flow [0.7 (0.5 to 0.8) to 4.4 (3.9 to 4.8) L . min(-1) per leg; median (range); P<0.001] were similar with both pumping modes. Normally, middle cerebral artery mean flow velocity increases from approximate to 50 to approximate to 65 cm . s(-1) during exercise, but in LVAD patients with a constant pump speed it was low at rest (39 +/- 14 cm . s(-1)) and remained unchanged during exercise, whereas in patients with increasing pump speed, it increased by 5.2 +/- 2.8 cm . s(-1) at 60 W (P<0.01). Conclusions-With maximal exercise, the axial-flow LVAD supports near-normal increments in cardiac output and leg perfusion, but cerebral perfusion is poor. Increased pump speed augments cerebral perfusion during exercise. (Circ Heart Fail. 2011; 4: 554-560.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Cardiac Characteristics of the First Two Waves of COVID-19 in Denmark and the Prognostic Value of Echocardiography: The ECHOVID-19 Study

Jacob Christensen, Filip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Mats Christian Hojbjerg Lassen, Alia Lassen, Alia Alhakak, Morten Sengelov, Anne Bjerg Nielsen, Niklas Dyrby Johansen, Henning Bundgaard, Christian Hassager, Reza Jabbari, Jorn Carlsen, Ole Kirk, Ole Peter Kristiansen, Olav Wendelboe Nielsen, Charlotte Suppli Ulrik, Pradeesh Sivapalan, Gunnar Gislason, Kasper Iversen, Jens Ulrik Staehr Jensen, Morten Schou, Anders Hviid, Tyra Grove Krause, Tor Biering-Sorensen

Summary: This study investigated whether the prognostic values of echocardiographic parameters changed with updates in treatment guidelines and the emergence of novel SARS-CoV-2 variants. The results showed that patients hospitalized during the second wave had worse left ventricular function, and reduced global longitudinal strain was associated with COVID-19-related mortality independently of wave, treatment, and SARS-CoV-2 variant.

CARDIOLOGY (2023)

Article Endocrinology & Metabolism

Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial

Niels H. Brandt-Jacobsen, Mikkel Jurgens, Philip Hasbak, Peter Gaede, Peter Rossing, Jon J. Rasmussen, Camillla Fuchs Andersen, Julie L. Forman, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Morten Schou, Caroline Kistorp

Summary: This study investigated the effects of short-term empagliflozin therapy on cardiac adipose tissue accumulation in patients with type 2 diabetes. The results showed that empagliflozin can reduce cardiac adipose tissue accumulation and improve weight and glucose metabolism. However, no correlation was observed between changes in cardiac volumetrics and cardiac adipose tissue accumulation.

DIABETES OBESITY & METABOLISM (2023)

Article Cardiac & Cardiovascular Systems

Soluble ST2 in plasma is associated with post-procedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarction

Frederik T. Sondergaard, Rasmus P. Beske, Martin Frydland, Jacob Eifer Moller, Ole K. L. Helgestad, Lisette Okkels Jensen, Lene Holmvang, Jens P. Goetze, Thomas Engstrom, Christian Hassager

Summary: This study found that pre-intervention plasma sST2 levels were associated with the post-procedural no-or-slow-reflow phenomenon in patients with ST-elevation myocardial infarction (STEMI), indicating that sST2 may serve as a potential biomarker to assess the extent of myocardial injury and predict prognosis in these patients.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Cardiac & Cardiovascular Systems

Management of comatose survivors of out-of-hospital cardiac arrest in Europe: current treatment practice and adherence to guidelines. A joint survey by the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Resuscitation Council (ERC), the European Society for Emergency Medicine (EUSEM), and the European Society of Intensive Care Medicine (ESICM)

Pablo Jorge-Perez, Nikolaos Nikolaou, Katia Donadello, Abdo Khoury, Wilhelm Behringer, Christian Hassager, Bernd Boettiger, Alessandro Sionis, Jerry Nolan, Alain Combes, Tom Quinn, Susanna Price, Johannes Grand

Summary: This study aimed to investigate adherence to guidelines and disparities in the treatment of out-of-hospital cardiac arrest (OHCA) in European hospitals. The results showed that there is inconsistency in the management of OHCA in European hospitals and deviations from international guidelines.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Cardiac & Cardiovascular Systems

Quality indicators for post-resuscitation care after out-of-hospital cardiac arrest: a joint statement from the Association for Acute Cardiovascular Care of the European Society of Cardiology, the European Resuscitation Council, the European Society of Intensive Care Medicine, and the European Society for Emergency Medicine

Johannes Grand, Francois Schiele, Christian Hassager, Jerry P. Nolan, Abdo Khoury, Alessandro Sionis, Nikolaos Nikolaou, Katia Donadello, Wilhelm Behringer, Bernd W. Boettiger, Alain Combes, Tom Quinn, Susanna Price, Pablo Jorge-Perez, Guido Tavazzi, Giuseppe Ristagno, Alain Cariou, Eric Bonnefoy Cudraz

Summary: This study proposes a set of quality indicators (QIs) for assessing the quality of post-out-of-hospital cardiac arrest management across Europe, with the aim of unifying and promoting quality care. These indicators include 6 primary QIs and 12 secondary QIs, ensuring reliability and accuracy through scientific methodology and selection.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2023)

Article Cardiac & Cardiovascular Systems

Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure

Abbas Ali Qayyum, Mette Mouridsen, Brian Nilsson, Ida Gustafsson, Morten Schou, Olav Wendelboe Nielsen, Jens Dahlgaard Hove, Anders Bruun Mathiasen, Erik Jorgensen, Steffen Helqvist, Francis Richard Joshi, Ellen Monsted Johansen, Bjarke Follin, Morten Juhl, Lisbeth Drozd Hojgaard, Mandana Haack-Sorensen, Annette Ekblond, Jens Kastrup

Summary: This study aimed to investigate the efficacy of allogeneic cell therapy for chronic ischaemic heart failure. Injections of Cardiology Stem Cell Centre Adipose tissue derived mesenchymal Stromal Cell (CSCC_ASC) were used as an add-on therapy, but no improvement in myocardial function, structure, or clinical symptoms was observed.

ESC HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Hyponatremia in stable patients with advanced heart failure: association to hemodynamics and outcome

Karoline Amalie Rask, Tania Deis, Johan Erik Larsson, Kasper Rossing, Finn Gustafsson

Summary: Hyponatremia is associated with worse outcomes in patients with chronic heart failure and reduced ejection fraction (HFrEF). This study aimed to investigate the potential association between hemodynamic derangement and hyponatremia in HFrEF patients. The study included 502 HFrEF patients who underwent a right heart catheterization. The results showed that lower sodium levels were associated with more deranged invasive hemodynamic measurements and hyponatremia was significantly associated with a composite endpoint in these patients.

CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology

Ovidiu Chioncel, Marianna Adamo, Maria Nikolaou, John Parissis, Alexandre Mebazaa, Mehmet Birhan Yilmaz, Christian Hassager, Brenda Moura, Johann Bauersachs, Veli-Pekka Harjola, Elena-Laura Antohi, Tuvia Ben-Gal, Sean P. Collins, Vlad Anton Iliescu, Magdy Abdelhamid, Jelena Celutkiene, Stamatis Adamopoulos, Lars H. Lund, Mariantonietta Cicoira, Josep Masip, Hadi Skouri, Finn Gustafsson, Amina Rakisheva, Ingo Ahrens, Andrea Mortara, Ewa A. Janowska, Abdallah Almaghraby, Kevin Damman, Oscar Miro, Kurt Huber, Arsen Ristic, Loreena Hill, Wilfried Mullens, Alaide Chieffo, Jozef Bartunek, Pasquale Paolisso, Antoni Bayes-Genis, Stefan D. Anker, Susanna Price, Gerasimos Filippatos, Frank Ruschitzka, Petar Seferovic, Rafael Vidal-Perez, Alec Vahanian, Marco Metra, Theresa A. McDonagh, Emanuele Barbato, Andrew J. S. Coats, Giuseppe M. C. Rosano

Summary: Acute heart failure (AHF) represents a wide range of disease states caused by the interaction between acute precipitants and a patient's underlying cardiac substrate and comorbidities. Valvular heart disease (VHD) is often associated with AHF. The severity of VHD and its correlation with symptoms can be difficult to assess in AHF patients due to various factors. Evidence-based interventions targeting VHD in AHF settings are yet to be identified, making current guidelines elusive. This scientific statement aims to provide an overview of the epidemiology, pathophysiology, and treatment approach for AHF patients with VHD.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Editorial Material Critical Care Medicine

Optimal oxygen and mean arterial blood pressure targets after cardiac arrest

Markus B. Skrifvars, Janet Bray, Christian Hassager

INTENSIVE CARE MEDICINE (2023)

Article Multidisciplinary Sciences

Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial

Morten H. Malmborg, Ali Assad Turky Al-Kahwa, Lars D. Kober, Christian K. Torp-Pedersen, Jawad Butt, Deewa Zahir, Christian Tuxen, Mikael Poulsen, Christian Madelaire, Emil Fosbol, Gunnar Gislason, Per Hildebrandt, Charlotte Andersson, Finn Gustafsson, Morten Schou

Summary: This study found that continued follow-up in specialized heart failure clinics did not improve long-term outcomes in HFrEF patients who had already received guideline-directed therapy. There is a need for the development and implementation of new monitoring strategies.

PLOS ONE (2023)

Letter Cardiac & Cardiovascular Systems

Diabetes and Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure: An Extended Follow-Up Analysis of DANISH

Seiko Nakajima Doi, Jens Jakob Thune, Jens Cosedis Nielsen, Jens Haarbo, Lars Videbaek, Rasmus Rorth, Soren Lund Kristensen, Niels Eske Bruun, Finn Gustafsson, Hans Eiskjaer, Christian Hassager, Jesper Hastrup Svendsen, Dan Eik Hofsten, Christian Torp-Pedersen, Steen Pehrson, Lars Kober, Jawad Haider Butt

CIRCULATION-HEART FAILURE (2023)

Article Endocrinology & Metabolism

The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

Mikkel Jurgens, Morten Schou, Philip Hasbak, Andreas Kjaer, Emil Wolsk, Bo Zerahn, Niels H. Brandt-Jacobsen, Peter Gaede, Peter Rossing, Jens Faber, Silvio E. Inzucchi, Finn Gustafsson, Caroline Kistorp

Summary: Empagliflozin has been found to reduce measured glomerular filtration rate (mGFR), estimated plasma volume (PV), and estimated extracellular volume (ECV) in patients with type 2 diabetes (T2D) and high risk of cardiovascular events. The 13-week randomized controlled trial showed a decrease in mGFR, ECV, and PV with the use of the drug.

DIABETES OBESITY & METABOLISM (2023)

Article Cardiac & Cardiovascular Systems

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial

Gerhard Poelzl, Johann Altenberger, Josep Comin-Colet, Juan F. Delgado, Francesco Fedele, Martin Jesus Garcia-Gonzalez, Finn Gustafsson, Josep Masip, Zoltan Papp, Stefan Stoerk, Hanno Ulmer, Sarah Maier, Bojan Vrtovec, Gerhard Wikstrom, Endre Zima, Axel Bauer, LeoDOR Investigators

Summary: The LeoDOR trial aimed to investigate the efficacy and safety of intermittent levosimendan therapy in patients with acute heart failure after hospitalization. The results showed that intermittent levosimendan therapy did not improve post-hospitalization clinical stability in patients recently hospitalized with reduced left ventricular ejection fraction.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Interatrial shunt devices for heart failure

Finn Gustafsson

Summary: Catheter-based creation of atrial shunts to relieve left atrial hypertension is being investigated as a treatment for heart failure. Trials so far have shown safety and efficacy in reducing left-sided cardiac filling pressures, and ongoing trials will determine the impact on clinical outcomes.

NATURE REVIEWS CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Temporal changes in the surgical management of patients with tetralogy of Fallot in Denmark: a nationwide cohort study

Mathis Groening, Morten Holdgaard Smerup, Dorte Guldbrand Nielsen, Henrik Nissen, Kim Munk, Ulrik Markus Mortensen, Helle Andersen, Morten Engholm, Jesper Bjerre, Niels Vejlstrup, Klaus Juul, Eva Vad Sondergaard, Annette Schophuus Jensen, Troels Hojsgaard Jorgensen, Hans Gustav Horsted Thyregod, Henrik orbaek Andersen, Christian Jons, Morten Helvind, Lars Sondergaard

Summary: This study aimed to assess temporal changes in the surgical management of patients with Tetralogy of Fallot, including the timing of interventions, surgical techniques, reinterventions, and survival. The results showed that in recent years, patients underwent earlier shunt palliation and intracardiac repair, with an increased use of transannular patches. Although survival rates have improved during childhood and adolescence, more patients undergo pulmonary valve replacement within the first 10 years after intracardiac repair.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2023)

No Data Available